These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 11580306)
1. Choosing the right dose of antipsychotics in schizophrenia: lessons from neuroimaging studies. Tauscher J; Kapur S CNS Drugs; 2001; 15(9):671-8. PubMed ID: 11580306 [TBL] [Abstract][Full Text] [Related]
2. Estimating dopamine D₂ receptor occupancy for doses of 8 antipsychotics: a meta-analysis. Lako IM; van den Heuvel ER; Knegtering H; Bruggeman R; Taxis K J Clin Psychopharmacol; 2013 Oct; 33(5):675-81. PubMed ID: 23948784 [TBL] [Abstract][Full Text] [Related]
3. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Kapur S; Zipursky R; Jones C; Remington G; Houle S Am J Psychiatry; 2000 Apr; 157(4):514-20. PubMed ID: 10739409 [TBL] [Abstract][Full Text] [Related]
4. Atypical antipsychotics: mechanism of action. Seeman P Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706 [TBL] [Abstract][Full Text] [Related]
5. A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone. Mamo D; Kapur S; Shammi CM; Papatheodorou G; Mann S; Therrien F; Remington G Am J Psychiatry; 2004 May; 161(5):818-25. PubMed ID: 15121646 [TBL] [Abstract][Full Text] [Related]
6. Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol. Tauscher J; Küfferle B; Asenbaum S; Tauscher-Wisniewski S; Kasper S Psychopharmacology (Berl); 2002 Jun; 162(1):42-9. PubMed ID: 12107616 [TBL] [Abstract][Full Text] [Related]
7. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Kapur S; Zipursky RB; Remington G Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565 [TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia. Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897 [TBL] [Abstract][Full Text] [Related]
9. [Theory in antipsychotic drug therapy for schizophrenia]. Tomioka S; Ishigooka J Seishin Shinkeigaku Zasshi; 2006; 108(6):614-8. PubMed ID: 16910539 [TBL] [Abstract][Full Text] [Related]
10. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. Kapur S; Seeman P Am J Psychiatry; 2001 Mar; 158(3):360-9. PubMed ID: 11229973 [TBL] [Abstract][Full Text] [Related]
11. Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the bench. Kapur S; Wadenberg ML; Remington G Can J Psychiatry; 2000 Apr; 45(3):241-6. PubMed ID: 10779880 [TBL] [Abstract][Full Text] [Related]
12. Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine. Tuppurainen H; Kuikka JT; Viinamäki H; Husso M; Tiihonen J Psychiatry Clin Neurosci; 2009 Aug; 63(4):529-37. PubMed ID: 19496999 [TBL] [Abstract][Full Text] [Related]
13. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics. Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652 [TBL] [Abstract][Full Text] [Related]
14. Antipsychotics, dopamine D₂ receptor occupancy and clinical improvement in schizophrenia: a meta-analysis. Yilmaz Z; Zai CC; Hwang R; Mann S; Arenovich T; Remington G; Daskalakis ZJ Schizophr Res; 2012 Sep; 140(1-3):214-20. PubMed ID: 22795368 [TBL] [Abstract][Full Text] [Related]
15. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. Kapur S; Zipursky RB; Remington G; Jones C; DaSilva J; Wilson AA; Houle S Am J Psychiatry; 1998 Jul; 155(7):921-8. PubMed ID: 9659858 [TBL] [Abstract][Full Text] [Related]
16. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride. Kegeles LS; Slifstein M; Frankle WG; Xu X; Hackett E; Bae SA; Gonzales R; Kim JH; Alvarez B; Gil R; Laruelle M; Abi-Dargham A Neuropsychopharmacology; 2008 Dec; 33(13):3111-25. PubMed ID: 18418366 [TBL] [Abstract][Full Text] [Related]
17. The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development. Talbot PS; Laruelle M Eur Neuropsychopharmacol; 2002 Dec; 12(6):503-11. PubMed ID: 12468013 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study. Graff-Guerrero A; Rajji TK; Mulsant BH; Nakajima S; Caravaggio F; Suzuki T; Uchida H; Gerretsen P; Mar W; Pollock BG; Mamo DC JAMA Psychiatry; 2015 Sep; 72(9):927-34. PubMed ID: 26131622 [TBL] [Abstract][Full Text] [Related]
19. Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine. Kapur S; Roy P; Daskalakis J; Remington G; Zipursky R Am J Psychiatry; 2001 Feb; 158(2):311-4. PubMed ID: 11156818 [TBL] [Abstract][Full Text] [Related]
20. Dose and dosing frequency of long-acting injectable antipsychotics: a systematic review of PET and SPECT data and clinical implications. Uchida H; Suzuki T J Clin Psychopharmacol; 2014 Dec; 34(6):728-35. PubMed ID: 24781442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]